Using Nanotechnology to Change the Tumor Environment for Treating Glioblastoma

Nanotechnology may improve therapeutic strategies for glioblastoma (GBM) by remodeling the tumour microenvironment.

• The glioblastoma tumour microenvironment involves complex interactions between tumour and non-tumour cells that promote tumour growth.
• Key therapeutic goals include enhancing immune cell effectiveness, inhibiting tumour growth, and improving the immunosuppressive environment.
• Nanoparticle-based drug delivery could enable more targeted treatment, improving specificity and facilitating combination therapies.
• Potential applications of nanotechnology include reducing immune cell suppression, inducing cell death in tumours, and regulating tumour metabolism.
• Modulating the interactions between tumour cells and other cells in the microenvironment may lead to improved treatment outcomes.

Simplified